| The impact of a sugar-sweetened beverages tax on oral health and costs of dental care in Australia PM Sowa, E Keller, N Stormon, R Lalloo, PJ Ford European journal of public health 29 (1), 173-177, 2019 | 61 | 2019 |
| Is there an optimal number of oocytes retrieved at which live birth rates or cumulative live birth rates per aspiration are maximized after ART? A systematic review YJ Law, N Zhang, EM Kolibianakis, MF Costello, E Keller, GM Chambers, ... Reproductive Biomedicine Online 42 (1), 83-104, 2021 | 28 | 2021 |
| How Much Is a Human Life Worth? A Systematic Review E Keller, JE Newman, A Ortmann, LR Jorm, GM Chambers Value in Health 24 (10), 1531-1541, 2021 | 24 | 2021 |
| Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency STF Shih, E Keller, V Wiley, MA Farrar, M Wong, GM Chambers International Journal of Neonatal Screening 8 (3), 45, 2022 | 16 | 2022 |
| Funding and public reporting strategies for reducing multiple pregnancy from fertility treatments GM Chambers, E Keller, S Choi, Y Khalaf, S Crawford, W Botha, ... Fertility and Sterility 114 (4), 715-721, 2020 | 16 | 2020 |
| What features of fertility treatment do patients value? Price elasticity and willingness-to-pay values from a discrete choice experiment E Keller, W Botha, GM Chambers Applied Health Economics and Health Policy 21 (1), 91-107, 2023 | 7 | 2023 |
| Valuing infertility treatment: Why QALYs are inadequate, and an alternative approach to cost-effectiveness thresholds E Keller, GM Chambers Frontiers in medical technology 4, 1053719, 2022 | 6 | 2022 |
| Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysis HY Sun, E Keller, H Suresh, DF Sebaratnam JAAD international 5, 1-8, 2021 | 6 | 2021 |
| Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency STF Shih, E Keller, V Wiley, M Wong, MA Farrar, GM Chambers International Journal of Neonatal Screening 8 (3), 44, 2022 | 5 | 2022 |
| Does in vitro fertilization (IVF) treatment provide good value for money? A cost-benefit analysis E Keller, W Botha, GM Chambers Frontiers in Global Women's Health 4, 971553, 2023 | 2 | 2023 |
| Freeze-all embryos during treatment with assisted reproduction: Health economic aspects C Venetis, E Keller, GM Chambers Best Practice & Research Clinical Obstetrics & Gynaecology 86, 102303, 2023 | 1 | 2023 |
| Gender inequality and utilization of ART: an international cross-sectional and longitudinal analysis O Fitzgerald, S Dyer, F Zegers-Hochschild, E Keller, GD Adamson, ... Human Reproduction 39 (1), 209-218, 2024 | | 2024 |
| Economic Evaluation of Fertility Treatment: Advancing the Research Agenda E Keller UNSW Sydney, 2023 | | 2023 |
| Exploring the Demand for Elective Egg Freezing: An Incentive-Compatible Experiment E Keller, A Ortmann, GM Chambers UNSW Business School Research Paper Forthcoming, 2022 | | 2022 |
| By the Numbers: Digital Health/Wearables IA Cox, A Singh, VM Pontinha, T Wagner, F Wolfrum, SV Dhayalan, ... Signal, 04, 2021 | | 2021 |
| PIH2 Does Fertility Treatment Provide Good VALUE for Money? a Cost-Benefit Analysis E Keller, W Botha, A Ortmann, LR Jorm, GM Chambers Value in Health Regional Issues 22, S44, 2020 | | 2020 |
Willings Botha, PhDUniversity of New South WalesVerified email at unsw.edu.au
